Insights

Market Leadership Lupin is a major global player with leadership in Anti-TB and a broad portfolio across cardiovascular, diabetology, asthma, CNS, GI, anti-infective and NSAIDs, presenting multiple cross-sell and expansion opportunities in branded and generic formulations and APIs.

Geographic Expansion Recent strategic partnerships to commercialize products in the EU, UK, Switzerland, Norway, and Iceland indicate a push into controlled markets with potential for co-marketing, licensing, and distribution partnerships.

FDA Activity Ongoing U.S. FDA approvals and launches (for injections and tablets) signal a pathway for entering or expanding in the U.S. market, suggesting opportunity for collaboration on manufacturing, supply chain, and access strategies.

Diverse Portfolio A broad product mix across generics, branded formulations, biotechnology products, and APIs enables tailored BD outreach to healthcare providers, payers, and contract manufacturing opportunities.

Scale and Growth With a sizeable workforce and multi-billion USD sales context, Lupin offers opportunities for strategic partnerships in manufacturing efficiency, digital tooling, and regional market penetration to accelerate top-line growth.

Similar companies to Lupin

Lupin Tech Stack

Lupin uses 8 technology products and services including Microsoft Power Apps, SAS, SOLIDWORKS, and more. Explore Lupin's tech stack below.

Media & News

Lupin's Email Address Formats

Lupin uses at least 4 email formats:
Lupin Email FormatsExamplePercentage
FirstLast@lupin.comJohnDoe@lupin.com
95%
FirstLas@lupin.comJohnDoe@lupin.com
3%
LastFir@lupin.comDoeJoh@lupin.com
1%
FirLast@lupin.comJohDoe@lupin.com
1%

Frequently Asked Questions

What is Lupin's stock symbol?

Minus sign iconPlus sign icon
Lupin is a publicly traded company; the company's stock symbol is LUPIN.BO.

What is Lupin's official website and social media links?

Minus sign iconPlus sign icon
Lupin's official website is lupin.com and has social profiles on LinkedIn.

How much revenue does Lupin generate?

Minus sign iconPlus sign icon
As of July 2026, Lupin's annual revenue is estimated to be <$10M.

What is Lupin's NAICS code?

Minus sign iconPlus sign icon
Lupin's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Lupin have currently?

Minus sign iconPlus sign icon
As of July 2026, Lupin has approximately 10K employees across 4 continents, including Asia, North America and Europe. Key team members include President: R. S., President - Global Human Resources: Y. G. and Deputy General Manager - Environment (corporate): M. M. Explore Lupin's employee directory with LeadIQ.

What industry does Lupin belong to?

Minus sign iconPlus sign icon
Lupin operates in the Pharmaceuticals industry.

What technology does Lupin use?

Minus sign iconPlus sign icon
Lupin's tech stack includes Microsoft Power Apps, SAS, SOLIDWORKS, CookieYes, WooCommerce, Marketo, Microsoft Azure and SAP Concur.

What is Lupin's email format?

Minus sign iconPlus sign icon
Lupin's email format typically follows the pattern of FirstLast@lupin.com. Find more Lupin email formats with LeadIQ.

When was Lupin founded?

Minus sign iconPlus sign icon
Lupin was founded in 1968.
Lupin logo

Lupin

PharmaceuticalsMaharashtra, India10001+ Employees

Lupin is a multinational pharmaceutical manufacturer based in Mumbai, India. The company focuses on developing and delivering a broad array of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients, with notable strengths across cardiovascular, diabetology, asthma, pediatric, CNS, GI, anti-infective, and NSAID markets, and a leadership position in the anti-TB segment. Its offerings aim to provide access to affordable, quality medicines across global markets, serving customers that require both established generics and innovative formulations. Lupin operates across the pharmaceutical industry with a footprint that spans multiple regions, including the United States, India, and Japan, and it positions itself as an innovation-led, transnational player in generic and branded drug development. The company is based in Bandra Kurla Complex, Mumbai, and has a sizable workforce, reflecting its scale in manufacturing and development activities. A recent development noted in public announcements includes regulatory approvals and product launches in the United States and China, indicating ongoing expansion and regulatory progress for its portfolio. } }# end of json }}

Section iconCompany Overview

Website
lupin.com
Stock Symbol
LUPIN.BO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1968
Employees
10001+

Section iconFunding & Financials

  • <$10M

    Lupin's revenue is estimated to be in the range of <$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.